Pancreatic Cancer and Thromboembolism in the Ambulatory Community

  • Davida A Kornreich Department of Medicine, Columbia University Medical Center. New York, NY, USA
  • Muhammad Wasif Saif Department of Medicine, Columbia University Medical Center. New York, NY, USA
DOI: https://doi.org/10.6092/1590-8577/691
Keywords: Ambulatory Care, Carcinoma, Pancreatic Ductal, Hematinics, Venous Thromboembolism

Abstract

Pancreatic exocrine adenocarcinoma is one of the most common malignancies associated with thromboembolism. The authors summarize the two abstracts (#368 and #273) presented at the 2012 ASCO Gastrointestinal Cancers Symposium which were focused on pancreatic thrombosis in ambulatory patients. In addition, they discuss the risk of thrombosis associated with malignancy, chemotherapy, and erythropoietin stimulating agents and the management and implications thereof.

Downloads

Download data is not yet available.

References

JW Blom. High risk of venous thrombosis in patients with pancreatic cancer. European Journal of Cancer. Volume 52, Issue 3, Feb 2006, pgs 410-414.

HK Chew et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med, 166(4) (2006), p 458-464.

S Paneesha et al. Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at oupatient DVT clinics. Thromb Haemost 2010; 103: 338–343

AA Khorana, CW Francis, E. Culakova, NM Kuderer, GH Lyman. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 2007; 5: 632–4.

GH Lyman et al. American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer. Journal of Clinical Oncology, Vol 25, No 34 (December 1), 2007: pp. 5490-5505

A Diab. Cancer-related venous thromboembolism: insight into underestimated risk factors. Hematol Oncol Stem Cell Ther 2010; 3(4): 191-195.

Ana Belen Ruperez Blanco, Andrés Jesús Muñoz Martin, Pilar Garcia Alfonso, Sonsoles Alvarez Suarez, Mercedes Cavanagh Podesta, Sara Custodio Cabello, et al. Incidence and prediction of venous thromboembolism (VTE) in ambulatory patients (pts) with pancreas cancer receiving chemotherapy. J Clin Oncol Abstract #368

Jay Lin, Mehul R. Dalal, Gregory Clayton Connolly, Alok A. Khorana. Evaluation of venous thromboembolism (VTE) risk among ambulatory patients with pancreatic cancer in a real-world setting. J Clin Oncol Abstract #273.

A Gerl. Vascular toxicity associated with chemotherapy for testicular cancer. Anticancer Drugs. 1994;5:607–614.

V Juneja, P Keegan, JE Gootenberg, MD Rothmann,YL Shen, KY Lee, KD Weiss, R Pazdur. Continuing reassessment of the risks of erythropoiesis-stimulating agents in patients with cancer. Clin Cancer Res. 2008 Jun 1;14(11):3242-7.

New York Presbyterian Hospital. New York, NY, USA
Published
2012-03-10
How to Cite
KornreichD., & SaifM. (2012). Pancreatic Cancer and Thromboembolism in the Ambulatory Community. JOP. Journal of the Pancreas, 13(2), 185-186. https://doi.org/10.6092/1590-8577/691
Issue
Vol 13 No 2 (2012): March - p. 124-251
Section
Highlights from the “2012 ASCO Gastrointestinal Cancers Symposium”. San Francisco, CA, USA. January 19-21, 2012

Copyright (c) 2014 Davida A Kornreich, Muhammad Wasif Saif

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.